# Study on Gene Evolution in Glioma Under Stress Therapy

> **NCT05512325** · — · NOT_YET_RECRUITING · sponsor: **Henan Provincial People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Genetic Change

## Interventions

- **DRUG:** Gene evolution and molecular response under Bevacizumab treatment

## Key facts

- **NCT ID:** NCT05512325
- **Lead sponsor:** Henan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-12-17
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05512325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05512325, "Study on Gene Evolution in Glioma Under Stress Therapy". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05512325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
